People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avid Radiopharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $63.1M | $1.2B | 2009 |
Matthew P. Rhodes-Kropf at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew P. Rhodes-Kropf on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ernest Mario | 1 | 9 |
| Gary J. Kurtzman | 1 | 6 |
| Richard A. Baron | 1 | 2 |
| William Hamilton | 1 | 2 |
| Ernest J. Mario | 1 | 1 |
| Alan P. Carpenter | 1 | 1 |
| Daniel M. Skovronsky | 1 | 1 |
| William A. Hamilton | 1 | 1 |
| Edward M. Hurwitz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.